Skip to main content
OpenTrials
Completed

NCT Number: NCT01833234

Epilepsy Impact Scale

The investigators are developing a questionnaire that can quickly measure the impact that epilepsy has on a person's life. This questionnaire will be useful in following whether the impact of epilepsy increases, decreases or stays the same over time. The results also may point out areas that would benefit from discussion or attention in visits with your doctor.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Epilepsy Brain Diseases Central Nervous System Diseases Nervous System Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Stanford University School of Medicine

Stanford, California, 94305-5235, United States

About this study

The investigators have used a set of broad open-ended questions about the impact of epilepsy on a person's life to formulate a long list of questions to characterize the impact the seizures, medications, and comorbidities that you are having. In the future, this will be boiled down to a short list of questions.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 or more.
  • Patient has had at least 1 seizure in the past 365 days.
  • Patient can speak and understand English.

Exclusion criteria

  • Patients suspected of having one of the imitators of epilepsy, for example, syncope, sleep disorder, psychogenic nonepileptic seizures, will be excluded, even if they also have epileptic seizures.
  • Patients unwilling to spend the time doing the questionnaire.

Treatment and study plan

Interviews and questionnaires

Other

Primary outcomes

  1. Validation of a concise question set

    Time frame: Up to 1 year for question set validation, data presentation within up to 1.5 years

Secondary outcomes

  1. Correlation of subscales

    Time frame: Up to 1.5 years

    Correlation of subscales of the study questionnaire with previously validated scales, including QoLiE-39, NHS Seizure Severity Scale, Liverpool side effects scale, Beck Depression Index

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Collaborators

  • James & Carrie Anderson Fund for Research in Epilepsy

Registry information

Official study title

Questionnaire Development for a Comprehensive Scale to Measure the Impact of Epilepsy on Life.

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Apr 16, 2013
Registry last updated
Apr 13, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.